In tribute to Axel Kahn who passed away on 6 July 2021, the IGH looks back on a rich day during which Axel Kahn honoured us with his presence.
On April 15, 2016 Axel Kahn spoke at the Genopolys amphitheatre as part of the Citizens' Days. The conference inaugurated the EUREKA cycle, with a reflection on the human being, this animal endowed with reason.
The Institute of Human Genetics of Montpellier (IGH) opens a call for applications to a Principal Investigator position in its main areas of interest, namely Genome Dynamics, Genomics, RNA Biology, Computational Biology and AI, Epigenetics, Immunogenetics, Developmental Biology, Cancer and Infectious Diseases.
New research will take place into the rare disease after charity Worldwide Cancer Research donated almost £200,000 to a French doctor's project.
The research is led by Dr Domenico Maiorano to better understand how a gene in DNA allows brain cancer cells to survive and grow.
The LifeTime initiative, in which the Institute of Human Genetics (IGH), the CNRS and the Institut Curie participate, brings together hundreds of researchers, clinicians, industry leaders and policy makers both in France and in Europe. Together, they publish their LifeTime Strategic Research Agenda as well as an article in Nature on September 7, 2020, providing their vision and a roadmap for the coming decade.
During the developing COVID-19 pandemic the Institute of Human Genetics and its researchers are playing their part in tackling the virus.
Pour célébrer cet anniversaire, l'IGH, en partenariat avec la nouvelle Faculté de Médecine de Montpellier, accueille un panel prestigieux de scientifiques internationaux pour une série de conférences.
This Wednesday, December 20, 2017, the MUSE board met to define and announce the final list of winning projects to the call for Research Support projects. 58 projects were selected out of 260 applications submitted, including the one led by William Richie from the Artificial Intelligence and Gene Regulation team at L'IGH.
María Moriel-Carretero, Sara Ovejero et Angelos Constantinou révèlent une connexion inattendue entre des protéines de l'AF et la machinerie de l'épissage des ARNs. Cette étude publiée le 13 octobre 2017 dans la revue Journal of Cell Biology, apporte un nouvel éclairage sur les syndromes myélodysplasiques.